Kerrie Brady is co-founder, and former Chief Business Officer and Executive Vice President, Corporate Strategy at Centrexion Therapeutics. She is an experienced international biopharmaceutical leader with a successful 30-year track record. Her focus has been founding entrepreneurial ventures and working with biopharma companies and research organizations on value creation for new and emerging technologies using her broad, cross-discipline, expertise in business, science and product development. Prior to founding Centrexion, Kerrie was co-founder and Chief Operations Officer for Vallinex Inc., Co-founder and Chief Operations Officer for Arcion Therapeutics Inc., and Founder and Chief Executive Officer of Traxion Therapeutics, Inc. Leading up to her entrepreneurial career Kerrie worked in both public and private biotechnology companies in business development and operations roles leveraging her experience in product management and regulatory affairs obtained working for major pharmaceutical companies. Kerrie holds a Bachelor of Pharmacy from Victorian College of Pharmacy, an MBA from the University of Melbourne and an M.S. in Biopharmaceuticals from the University of New South Wales.
3:30 PM - 4:25 PM (PDT)
Wednesday, June 10
BIO International Convention attendees in San Diego will have the opportunity to hear how a diverse…